These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18533403)

  • 1. Counseling breast cancer patients on contralateral prophylactic mastectomy: the physician's role.
    Tuttle TM
    Oncology (Williston Park); 2008 Apr; 22(5):545-8. PubMed ID: 18533403
    [No Abstract]   [Full Text] [Related]  

  • 2. The rise in bilateral mastectomies: Evidence, ethics, and physician's role.
    Yang YT; Pike ER; Rose CM; Botnick LE
    Breast; 2016 Oct; 29():160-2. PubMed ID: 27518147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
    Tuttle TM; Habermann EB; Grund EH; Morris TJ; Virnig BA
    J Clin Oncol; 2007 Nov; 25(33):5203-9. PubMed ID: 17954711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic mastectomy in women at high risk for breast and ovarian cancer: qualitative analysis of the decision making process and long-term satisfaction of two women carrying a BRCA1-mutation].
    Vodermaier A; Bauerfeind I; Untch M; Nestle-Krämling C
    Psychother Psychosom Med Psychol; 2006; 56(9-10):351-61. PubMed ID: 16804803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
    Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary breast cancer: shared communication and care.
    Rayson D; Steele P; Collins K; Babineau T
    J Clin Oncol; 2003 Dec; 21(24):4660; author reply 4660. PubMed ID: 14673068
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast reconstruction after bilateral prophylactic mastectomy in women at high risk for breast cancer.
    Eldor L; Spiegel A
    Breast J; 2009; 15 Suppl 1():S81-9. PubMed ID: 19775335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contralateral prophylactic mastectomy for patients with unilateral breast cancer.
    Tuttle T; Habermann E; Abraham A; Emory T; Virnig B
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1117-22. PubMed ID: 18028020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.
    Metcalfe KA; Esplen MJ; Goel V; Narod SA
    Psychooncology; 2004 Jan; 13(1):14-25. PubMed ID: 14745742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted tailored management of the breast cancer patient at risk for harboring a germline mutation-current trends affecting the selection of patients considering surgical prophylaxis for breast cancer.
    Silva E
    Breast J; 2009; 15 Suppl 1():S76-80. PubMed ID: 19775334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic mastectomy and genetic testing: an update.
    Houshmand SL; Campbell CT; Briggs SE; McFadden AW; Al-Tweigeri T
    Oncol Nurs Forum; 2000; 27(10):1537-47; quiz 1548-9. PubMed ID: 11103373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral prophylactic mastectomy: issues and concerns.
    Stefanek ME
    J Natl Cancer Inst Monogr; 1995; (17):37-42. PubMed ID: 8573451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy.
    Geiger AM; West CN; Nekhlyudov L; Herrinton LJ; Liu IL; Altschuler A; Rolnick SJ; Harris EL; Greene SM; Elmore JG; Emmons KM; Fletcher SW
    J Clin Oncol; 2006 Mar; 24(9):1350-6. PubMed ID: 16549829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of and satisfaction with bilateral prophylactic mastectomy.
    Stefanek ME; Helzlsouer KJ; Wilcox PM; Houn F
    Prev Med; 1995 Jul; 24(4):412-9. PubMed ID: 7479633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic mastectomy: an appraisal.
    Zagouri F; Chrysikos DT; Sergentanis TN; Giannakopoulou G; Zografos CG; Papadimitriou CA; Zografos GC
    Am Surg; 2013 Feb; 79(2):205-12. PubMed ID: 23336662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contralateral prophylactic mastectomy: mind the genetics.
    Briasoulis E; Roukos DH
    J Clin Oncol; 2008 Apr; 26(11):1909-10; author reply 1910. PubMed ID: 18398162
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient-physician concordance: preferences, perceptions, and factors influencing the breast cancer surgical decision.
    Janz NK; Wren PA; Copeland LA; Lowery JC; Goldfarb SL; Wilkins EG
    J Clin Oncol; 2004 Aug; 22(15):3091-8. PubMed ID: 15284259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When is contralateral mastectomy warranted in unilateral breast cancer?
    Barry M; Sacchini V
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1209-14. PubMed ID: 21916574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic mastectomy: is it worth it?
    de la Peña-Salcedo JA; Soto-Miranda MA; Lopez-Salguero JF
    Aesthetic Plast Surg; 2012 Feb; 36(1):140-8. PubMed ID: 21751064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.